Morgan Stanley Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400

Benzinga · 1d ago
Morgan Stanley analyst Kallum Titchmarsh upgrades West Pharmaceutical Servs (NYSE:WST) from Equal-Weight to Overweight and raises the price target from $365 to $400.